Tecan Group AG (TCGGY)
- Previous Close
0.00 - Open
34.63 - Bid 38.10 x --
- Ask 40.01 x --
- Day's Range
34.63 - 34.63 - 52 Week Range
34.63 - 83.50 - Volume
4 - Avg. Volume
1 - Market Cap (intraday)
2.419B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
27.91 - EPS (TTM)
1.29 - Earnings Date Mar 12, 2025
- Forward Dividend & Yield 0.74 (2.04%)
- Ex-Dividend Date Apr 15, 2025
- 1y Target Est
--
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
www.tecan.com3,074
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TCGGY
View MorePerformance Overview: TCGGY
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TCGGY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TCGGY
View MoreValuation Measures
Market Cap
2.48B
Enterprise Value
2.38B
Trailing P/E
28.04
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.03
Price/Book (mrq)
1.32
Enterprise Value/Revenue
2.12
Enterprise Value/EBITDA
13.37
Financial Highlights
Profitability and Income Statement
Profit Margin
7.24%
Return on Assets (ttm)
2.08%
Return on Equity (ttm)
4.86%
Revenue (ttm)
934.28M
Net Income Avi to Common (ttm)
67.66M
Diluted EPS (ttm)
1.29
Balance Sheet and Cash Flow
Total Cash (mrq)
406.01M
Total Debt/Equity (mrq)
22.39%
Levered Free Cash Flow (ttm)
101.22M